Dose-Ranging Study to Assess the Safety and Efficacy of Melatonin in Outpatients Infected With COVID-19
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
A pilot placebo-controlled randomized double-blind trial of Melatonin in outpatients with
COVID-19 infection to evaluate Safety, Efficacy and Dose-ranging.
Phase:
Phase 2
Details
Lead Sponsor:
State University of New York at Buffalo
Collaborator:
National Center for Advancing Translational Science (NCATS)